News

Takeda Global R&D Centre Europe (TGRD EU) submitted the marketing authorization application (MAA) for ramelteon in Europe in March 2007. The Committee for Medicinal Products for Human Use

Clinically tested in France, Breathe Again is said to be 100% natural, combining the benefits of pure seawater and the drying effect of a hypertonic solution. According to

MediCult has entered into a share purchase agreement with Terry Fortino, president and majority shareholder of MidAtlantic Diagnostics, to purchase the entire issued share capital for an up-front

The new reactor is the latest in a series of investments designed to enhance production capacity and expand capabilities at the Arklow site, which is the company’s global

The Committee for Medicinal Products for Human Use’s (CHMP’s) positive opinion is now referred for final action to the European Commission, which grants approval in the EU. The

The additional data showed that Triolex is safe and well tolerated to date, and that it significantly improved insulin sensitivity and lowered fasting blood glucose and insulin levels

Mr Kennedy was most recently a member of senior management and an executive director of Cozart, a medical diagnostics company specializing in drugs-of-abuse testing in the UK and

Previously, Ipsen has exclusively in-licensed from Debiopharm know-how and new patent applications for the commercialization rights of the new six-month formulation of Decapeptyl in the world excluding North

Mr Barlow will continue to serve out his term as a member of the company’s board of directors. The company had begun a search to identify a permanent